Literature DB >> 9696821

Equine infectious anemia virus is found in tissue macrophages during subclinical infection.

J L Oaks1, T C McGuire, C Ulibarri, T B Crawford.   

Abstract

The equine infectious anemia virus (EIAV) often results in lifelong subclinical infection following early episodes of clinical disease. To identify the cellular reservoirs of EIAV during subclinical infection, horses were infected with EIAV and allowed to develop subclinical infections. Horses with acute disease served as a basis for comparison. The tissue distribution, replication status, location of infected cells, and viral load were characterized by PCR for proviral DNA and reverse transcriptase PCR for viral RNA, in situ hybridization, and in situ PCR. Proviral DNA was widespread in tissues regardless of disease status. Viral gag and env RNAs were also detected in tissues of all horses regardless of disease status. Plasma viral RNA (viremia) could be detected in some, but not all, horses with subclinical infections. In situ assays determined that a primary cellular reservoir and site of viral replication during subclinical infection is the macrophage. During subclinical infection, viral load was decreased 4- to 733-fold and there was decreased viral RNA expression within infected cells. These data indicate that viral replication continues at all times, even in horses that are clinically quiescent. Moreover, restricted viral replication at the cellular level is associated with clinical remission.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696821      PMCID: PMC109949     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  A primary production deficit in the thrombocytopenia of equine infectious anemia.

Authors:  T B Crawford; K J Wardrop; S J Tornquist; E Reilich; K M Meyers; T C McGuire
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

3.  Phorbol ester stimulation of equine macrophage cultures alters expression of equine infectious anemia virus.

Authors:  D C Sellon; K M Walker; K E Russell; S T Perry; F J Fuller
Journal:  Vet Microbiol       Date:  1996-10       Impact factor: 3.293

Review 4.  Molecular biology and pathogenesis of animal lentivirus infections.

Authors:  J E Clements; M C Zink
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

5.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.

Authors:  G Pantaleo; S Menzo; M Vaccarezza; C Graziosi; O J Cohen; J F Demarest; D Montefiori; J M Orenstein; C Fox; L K Schrager
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

6.  Correlates of protection in HIV infection and the progression of HIV infection to AIDS.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Lett       Date:  1996-06       Impact factor: 3.685

7.  Rapid detection of bovine viral diarrhea virus by using RNA extracted directly from assorted specimens and a one-tube reverse transcription PCR assay.

Authors:  A L Hamel; M D Wasylyshen; G P Nayar
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

8.  Equine infectious anemia virus replication is upregulated during differentiation of blood monocytes from acutely infected horses.

Authors:  D C Sellon; K M Walker; K E Russell; S T Perry; P Covington; F J Fuller
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Detection of equine infectious anemia viral RNA in plasma samples from recently infected and long-term inapparent carrier animals by PCR.

Authors:  J L Langemeier; S J Cook; R F Cook; K E Rushlow; R C Montelaro; C J Issel
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

10.  Distribution of SIV in lymph nodes of serially sacrificed rhesus monkeys.

Authors:  G B Baskin; L N Martin; M Murphey-Corb; F S Hu; D Kuebler; B Davison
Journal:  AIDS Res Hum Retroviruses       Date:  1995-02       Impact factor: 2.205

View more
  21 in total

1.  Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.

Authors:  S A Hammond; F Li; B M McKeon; S J Cook; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Characterization of a cytolytic strain of equine infectious anemia virus.

Authors:  Wendy Maury; Patrick J Wright; Sarahann Bradley
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

3.  Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype.

Authors:  Prasith Baccam; Robert J Thompson; Yuxing Li; Wendy O Sparks; Michael Belshan; Karin S Dorman; Yvonne Wannemuehler; J Lindsay Oaks; James L Cornette; Susan Carpenter
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.

Authors:  Robert Hines; Brenda R Sorensen; Madeline A Shea; Wendy Maury
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

5.  The risk of introduction of equine infectious anemia virus into USA via cloned horse embryos imported from Canada.

Authors:  B D Asseged; T Habtemariam; B Tameru; D Nganwa
Journal:  Theriogenology       Date:  2011-09-29       Impact factor: 2.740

6.  Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.

Authors:  S M Harrold; S J Cook; R F Cook; K E Rushlow; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.

Authors:  Sandra D Taylor; Steven R Leib; Wuwei Wu; Robert Nelson; Susan Carpenter; Robert H Mealey
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

8.  Endocytosis and a low-pH step are required for productive entry of equine infectious anemia virus.

Authors:  Melinda A Brindley; Wendy Maury
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

9.  Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.

Authors:  Hal P Bogerd; Rebecca L Tallmadge; J Lindsay Oaks; Susan Carpenter; Bryan R Cullen
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

10.  EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages.

Authors:  Lina Covaleda; Frederick J Fuller; Susan L Payne
Journal:  Virology       Date:  2009-11-28       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.